THE ROLE OF AT-HOME CONSUMER DIAGNOSTICS INCREASES Saliva-based home pregnancy test arrives at Australian pharmacies
With
Dr Anita Sharma, GP
Platinum Medical Centre,
Brisbane
Michael Cima, CEO & Director
CC Supplies,
Byron Bay
SEGMENT
Filmed in Brisbane | March 2026
Since the COVID-19 pandemic, consumer diagnostics have rapidly advanced, with more people becoming aware of and comfortable using at-home testing. These tests provide greater convenience, control, and empowerment, allowing individuals to monitor their health without immediately consulting a healthcare professional. Recently, this shift has been particularly impactful in areas such as pregnancy testing, where saliva-based diagnostics now enable earlier and more accessible detection.
According to Dr Anita Sharma, a Brisbane based GP at Platinum Medical Centre, traditional medical testing still plays an important role. Situations such as unclear symptoms, early-stage conditions with low detectable markers, or practical limitations—like insufficient saliva samples—may require confirmation through standard clinical methods. Additionally, many patients seek reassurance from healthcare professionals even after receiving positive at-home results, particularly when further care planning is needed.
As a result, the role of healthcare practitioners is evolving, according to Dr Sharma. Rather than acting solely as gatekeepers to testing, they are increasingly becoming interpreters and validators of patient-led diagnostics. According to Dr Sharma, GPs now focus more on guiding care, confirming results, and supporting patient decisions. To do this effectively, Dr Sharma states GPs must stay informed through continuous education, engagement with peers, and awareness of emerging diagnostic technologies and trends in healthcare.
Australian Health Journal also spoke with Michael Cima, CEO and Director of CC Supplies about the accessibility of consumer diagnostics and where women are able to choose how to test, have improved access and opt for privacy.
Source: Adapted from transcript
You Might also like
-
Addressing Wound Management
The cost of chronic wounds in Australia is estimated to be $3 Billion per year, impacting 420,000 Australians. Not only is this a national economic concern, but more importantly, is the suffering the person may be going through.
Australian Health Journal met with Hayley Ryan, Board Director and Chair at Wounds Australia and Director at WoundRescue to hear her work in chronic wound management, palliative wounds and pressure injury prevention to comfort those living with a wound.
-
Understanding factors of persistent lower back pain in women
Lizzy Quinn is a Musculoskeletal Physiotherapist with 20 years experience focusing on people with spinal pain. Australian Health Journal spoke with Lizzy on the complexities of persistent lower back pain in women.
Lower back pain in women in their 30s, 40s, and 50s is complex to treat due to the combination of physical and emotional factors, and health professionals need to stay updated on best practices and science to provide the best recovery platform for patients. These women typically have busy lives, pressures, and expectations.
-
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.